Compare BMBL & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMBL | CTKB |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.9M | 777.3M |
| IPO Year | 2021 | 2021 |
| Metric | BMBL | CTKB |
|---|---|---|
| Price | $6.00 | $5.95 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $4.21 | ★ $6.17 |
| AVG Volume (30 Days) | ★ 11.7M | 1.2M |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $965,658,000.00 | $193,015,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $6.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $2.44 | $3.31 |
| 52 Week High | $6.00 | $6.34 |
| Indicator | BMBL | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 87.42 | 55.31 |
| Support Level | $2.62 | $4.10 |
| Resistance Level | $6.00 | $6.27 |
| Average True Range (ATR) | 0.03 | 0.35 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 92.86 | 59.82 |
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.